Prediagnosis Psychiatric Care Linked to Worse Cancer Mortality
Higher cancer-specific, all-cause mortality seen with increasing intensity of prediagnosis psychiatric care
WEDNESDAY, March 13, 2019 (HealthDay News) -- Precancer psychiatric utilization (PU) is associated with worse cancer-specific mortality (CSM) and all-cause mortality (ACM) among adults with solid organ malignancies, according to a study recently published in the British Journal of Cancer.
Zachary Klaassen, M.D., from the University of Toronto, and colleagues included data for 676,125 residents of Ontario diagnosed with one of the top 10 malignancies from 1997 to 2014. The psychiatric utilization gradient (PUG) score was examined in the five years prior to cancer diagnosis (0: none; 1: outpatient; 2: emergency department; 3: hospital admission). The authors examined the impact of the PUG score on CSM and ACM.
The researchers found that 53.2, 45.0, 1.2, and 0.6 percent of patients had PUG scores of 0, 1, 2, and 3, respectively. An independent correlation was observed for increasing PUG score with worse CSM, with an effect gradient across the intensity of prediagnosis PU versus PUG 0 of 1.05, 1.36, and 1.73 for PUG 1, 2, and 3, respectively. A correlation was also noted for increasing PUG score with worse ACM.
"Patients with intense psychiatric utilization prior to diagnosis are more likely to suffer CSM compared to patients without psychiatric utilization," the authors write. "The specific factors underlying the observed associations remain to be elucidated."